Cardiac shock wave therapy attenuates H9c2 myoblast apoptosis by activating the AKT signal pathway

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1293-1303

  Yu, Weiwei ^a,b   Shen, Tao ^c   Liu, Baoyi ^b   Wang, Shu ^c   Li, Jian ^c   Dai, Dapeng ^c   Cai, Jianping ^c   He, Qing ^a,b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

AKT; Apoptosis; Cardiac Shock Wave Therapy; Ischemia Hypoxia

Indexed keywords

CASPASE 3; HOE 33342; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PHOSPHATIDYLINOSITOL 3 KINASE;

APOPTOSIS; ARTICLE; CARDIAC SHOCK WAVE THERAPY; CELL DEATH; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACORPOREAL LITHOTRIPSY; FLOW CYTOMETRY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MTT ASSAY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL CELL; CELL HYPOXIA; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; SHOCK WAVE LITHOTRIPTER; ANIMAL; DIATHERMY; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; RAT;

SUS;

ANIMALS; APOPTOSIS; MYOCARDIAL ISCHEMIA; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SHORT-WAVE THERAPY; SIGNAL TRANSDUCTION;

EID: 84899612414     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358697     Document Type: Article

References (43)

1. Jess up M, Brozena S: Heart failure. N Engl J Med 2003;348:2007-2018.
2. Morrison D, Sacks J: Balancing benefit against risk in the choice of therapy for coronary artery disease: Lesson from prospective, rando mized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Minerva Cardioangiol 2003;51:585-597. (Pubitemid 38029785)
3. Angina R: The problem of chronic refractory angina. Eur Heart J 2002;23:355-370.
4. Nishida T Shimokawa H Oi K Tatewaki H Uwatoku T Abe K Matsumoto Y Kajihara N Eto M Matsuda T Extracorporeal cardiac shock wave therapy markedly ameliorates isch emia-induced myocardial dysfunction in pigs in vivo Circulation 2004 110 3055-3061. (Pubitemid 39491998)
5. Ito K, Fukumoto Y, Shimokawa H: Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. Tohoku J Exp Med 2009;219:1-9.
6. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, Takeshita A, Sunagawa K, Shimokawa H: Extracorporeal cardiac shock wave therapy ameliorates myocardi al ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006;17:63-70. (Pubitemid 44365923)
7. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert S, Cigola E, Anversa P: Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-2016. (Pubitemid 26340560)
8. Saraste A, Pulkki K, Kall ajoki M, Henriksen K, Parvinen M, Voipio-Pulkki L-M: Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-323. (Pubitemid 27056193)
9. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189. (Pubitemid 26339772)
10. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, Anversa P: Myocyte death in the failing human heart is gender dependent. Circ Res 1999;85:856-866. (Pubitemid 29504161)
11. Yaoi ta H, Ogawa K, Maehara K, Maruyama Y: Attenuation of ischemia /reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-281. (Pubitemid 28067314)
12. Holly TA, Drincic A, Byun Y, Nakamura S, Ha rris K: Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999;31:1709-1715. (Pubitemid 29414590)
13. Huang JQ, Radinovic S, Rezaiefar P, Black SC: In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia. Eur J Pharmacol 2000;402:139-142. (Pubitemid 30625320)
14. Wencker D, Chandra M, Nguyen K: A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003;111:1497-1504. (Pubitemid 38063282)
15. Tao Shen, Yuping Zhu, Jigar Patel, Yang Ruan, Beidong Chen, Gexin Zhao, Yuan Cao, Jing Pang, Hangbang Guo, Hongxia Li, Yong Man, Shu Wang, Jian Li: T-Box20 Suppresses Oxidized Low-Density Lipoprotein-induced Human Vascular Endothelial Cell Injury by Upregulation of PPAR-y. Cell Physiol Biochem 2013;32:1137-1150.
16. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991;69:1476-1486.
17. Liu X-h, Chen P-f, Pan L-l, De Silva R, Zhu Y-z. 4-Guanidino-n-butyl syringate (Leonurine, SCM 198) protects H9c2 rat ventricular cells from hypoxia-induced apoptosis. J Cardiovasc Pharmacol 2009;54:437-444 .
18. Bonavita F, Stefanelli C, Giordano E, Columbaro M, Facchini A, Bonafe F, et al. H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: Inhibition by PMA. FEBS Lett 2003;536:85-91. (Pubitemid 36206411)
19. Ekhterae D, Lin Z, Lundberg MS, Crow MT, Brosius FC, Nunez G. ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res 1999;85:e70-e7.
20. Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN, Aronova EM, Ivanova SV: Initial clinical experience with ex tracorporeal shock wave therapy in treatment of ischemic heart failure. Congest Heart Fail 2010;16:226-230.
21. Schmid JP, Capoferri M, Wahl A, Eshtehardi P, Hess OM: Cardiac Shock Wave Therapy for Chr onic Refractory Angina Pectoris. A Prospective Placebo-Controlled Randomized Trial. Cardiovasc Ther 2013;31:el-e6.
22. Kazmi WH, Rasheed SZ, Ahmed S, Saadat M, Altaf S, Samad A: Noninvasive therapy for the management of patients with advanced coronary artery disease. Coron Artery Dis 2012;23:549-554.
23. Sobczak M, Kasprzak JD: Cardiac shock wave therapy-A new method for treatment of advanced coronary disease and refractory angina. Kardiol Pol 2010;68:1391.
24. Gutersohn A, Caspari G, Erbel R: Short and long term clinical improvement in patients with refractory angina using cardiac shock wave therapy (CSWT). Circ J 2005;69:S378.
25. Tanaka M, Ito H, A dachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M: Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-433 . (Pubitemid 24256403)
26. Kajstura J Cheng W Reiss K Clark WA Sonnenblick EH Krajewski S Reed JC Olivetti G Anversa P Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats Lab Invest 1996 74 86-107. (Pubitemid 26041012)
27. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apop tosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998;101:1326.
28. Scorrano L, Ashiya M, Buttle K, Weiler S, O akes SA, Mannella CA, Korsmeyer SJ: A Distinct Pathway Remodels Mitochondrial Cristae and Mobilizes Cytochrome c during Apoptosis. Dev Cell 2002;2:55-67. (Pubitemid 34065906)
29. Tatsumi T, Shiraishi J, Keira N, Akashi K, Mano A, Yamanaka S, Matoba S, Fushiki S, Fliss H, Nakagawa M: Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc Res 2003;59:428-440. (Pubitemid 37272037)
30. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136. (Pubitemid 27097313)
31. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132. (Pubitemid 27097312)
32. Mis ao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H: Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circu lation 1996;94:1506-1512. (Pubitemid 26320251)
33. Nishikawa S, Tatsumi T, Shiraishi J, Matsunaga S, Takeda M, Mano A, Kobara M, Keira N, Okigaki M, Takahashi T: Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induce d apoptosis. J Mol Cell Cardiol 2006;40:510-519.
34. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, Shimokawa H: Extracorporeal cardiac shock wave therapy improves left ventricular remodel ing after acute myocardial infarction in pigs. Coron Artery Dis 2007;18:397-404. (Pubitemid 47186841)
35. Yao R, Cooper GM: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267:2003-2006.
36. Gajewski TF, Thompson CB: Apoptosis meets signal transduction: Elimination of a BAD influence. Cell 1996;87:589-592. (Pubitemid 26386932)
37. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-689. (Pubitemid 27464966)
38. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241. (Pubitemid 27456390)
39. Ja rgin SV: Shock wave therapy of ischemic heart disease in the light of general pathology. Int J Cardiol 2010;144:116-117.
40. Jargin SV: Shock wave therapy of ischemic heart disease: Some aspects of publication and advertizing in Russia. Int J Cardiol 2010;145:241-242.
41. Di Meglio F, Nurzynska D, Castaldo C, Miraglia R, Romano V, De Angelis A, Piegari E, Russo S, Montagnani S: Cardiac shock wa ve therapy: Assessment of safety and new insights into mechanisms of tissue regeneration. J Cell Mol Med 2012;16:936-942.
42. Fu M, Sun C-K, Lin Y-C, Wang C-J, Wu C-J, Ko S-F, Chua S, Sheu J-J, Chiang C-H, Shao P-L, Leu S, Yip H-K: Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: Molecular-cellular and functional assessment. PLoS One 2011;6:e24342.
43. Aicher A, Heeschen C, Sasaki K-i, Urbich C, Zeiher AM, Dimmeler S: Low-Energy ShockWave for Enhancing Recruitment of Endothelial Progenitor Cells A New Modality to Increase Efficacy of Cell Therapy in Chronic Hind L imb Ischemia. Circulation 2006;114:2823-2830. (Pubitemid 46018285)